These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11535310)

  • 21. Suspension of rotavirus vaccine after reports of intussusception--United States, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Sep; 53(34):786-9. PubMed ID: 15343145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intussusception among recipients of rotavirus vaccine--United States, 1998-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(27):577-81. PubMed ID: 10428095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse events following Haemophilus influenzae type b vaccines in the Vaccine Adverse Event Reporting System, 1990-2013.
    Moro PL; Jankosky C; Menschik D; Lewis P; Duffy J; Stewart B; Shimabukuro TT
    J Pediatr; 2015 Apr; 166(4):992-7. PubMed ID: 25598306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Post-licensure passive safety surveillance of rotavirus vaccines: reporting sensitivity for intussusception].
    Pérez-Vilar S; Díez-Domingo J; Gomar-Fayos J; Pastor-Villalba E; Sastre-Cantón M; Puig-Barberà J
    An Pediatr (Barc); 2014 Aug; 81(2):77-85. PubMed ID: 24252603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and reactogenicity of DTPa-HBV-IPV/Hib and DTPa-IPV/I-Hib vaccines in a post-marketing surveillance setting.
    Lim FS; Phua KB; Lee BW; Quak SH; Teoh YL; Ramakrishnan G; Han HH; Van Der Meeren O; Jacquets JM; Bock HL
    Southeast Asian J Trop Med Public Health; 2011 Jan; 42(1):138-47. PubMed ID: 21323176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major Birth Defects after Vaccination Reported to the Vaccine Adverse Event Reporting System (VAERS), 1990 to 2014.
    Moro PL; Cragan J; Lewis P; Sukumaran L
    Birth Defects Res; 2017 Jul; 109(13):1057-1062. PubMed ID: 28762675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The temporal relationship between RotaTeq immunization and intussusception adverse events in the Vaccine Adverse Event Reporting System (VAERS).
    Geier DA; King PG; Sykes LK; Geier MR
    Med Sci Monit; 2012 Feb; 18(2):PH12-17. PubMed ID: 22293889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015.
    Miller ER; Lewis P; Shimabukuro TT; Su J; Moro P; Woo EJ; Jankosky C; Cano M
    Hum Vaccin Immunother; 2018; 14(8):1963-1969. PubMed ID: 29580194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010.
    Moro PL; Yue X; Lewis P; Haber P; Broder K
    Vaccine; 2011 Nov; 29(50):9404-8. PubMed ID: 21920404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rotavirus live, oral, pentavalent vaccine.
    Tom-Revzon C
    Clin Ther; 2007 Dec; 29(12):2724-37. PubMed ID: 18201590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barré syndrome.
    Miller ER; McNeil MM; Moro PL; Duffy J; Su JR
    Vaccine; 2020 Nov; 38(47):7458-7463. PubMed ID: 33039207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uptake and timeliness of rotavirus vaccination in Norway: The first year post-introduction.
    Valcarcel Salamanca B; Hagerup-Jenssen ME; Flem E
    Vaccine; 2016 Sep; 34(39):4684-4689. PubMed ID: 27522178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Active surveillance of vaccine safety: a system to detect early signs of adverse events.
    Davis RL; Kolczak M; Lewis E; Nordin J; Goodman M; Shay DK; Platt R; Black S; Shinefield H; Chen RT
    Epidemiology; 2005 May; 16(3):336-41. PubMed ID: 15824549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.
    Knuf M; Habermehl P; Cimino C; Petersen G; Schmitt HJ
    Vaccine; 2006 May; 24(22):4727-36. PubMed ID: 16616973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced surveillance of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines in pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2011-2015.
    Moro PL; Cragan J; Tepper N; Zheteyeva Y; Museru O; Lewis P; Broder K
    Vaccine; 2016 Apr; 34(20):2349-53. PubMed ID: 27013434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007.
    Haber P; Patel M; Izurieta HS; Baggs J; Gargiullo P; Weintraub E; Cortese M; Braun MM; Belongia EA; Miller E; Ball R; Iskander J; Parashar UD
    Pediatrics; 2008 Jun; 121(6):1206-12. PubMed ID: 18519491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015.
    Arana JE; Harrington T; Cano M; Lewis P; Mba-Jonas A; Rongxia L; Stewart B; Markowitz LE; Shimabukuro TT
    Vaccine; 2018 Mar; 36(13):1781-1788. PubMed ID: 29477308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. U.S. Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005-2007.
    Chang S; O'Connor PM; Slade BA; Woo EJ
    Vaccine; 2013 Feb; 31(10):1447-52. PubMed ID: 23142308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018.
    Su JR; McNeil MM; Welsh KJ; Marquez PL; Ng C; Yan M; Cano MV
    Vaccine; 2021 Jan; 39(5):839-845. PubMed ID: 33422381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.